Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    An Electrolytically Prepared Colloidal Silver Preparation Protects against Citrate-induced Toxicity in Artemia franciscana Nauplii

    Web AdminBy Web AdminApril 10, 2024Updated:April 19, 2024No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Ian Edwin Cock1, 2,*, Michael Whitehouse2
    1Centre for Planetary Health and Food Security, Griffith University, Nathan, AUSTRALIA.
    2School of Environment and Science, Griffith University, Nathan, AUSTRALIA.

    DOI: 10.5530/pc.2024.2.12

    ABSTRACT

    Introduction: Nanotechnology is promising for the development of new effective medicines. Silver nanoparticle preparations have been particularly well studied and a range of beneficial effects have been identified. Despite this, the sale of Colloidal silver (CS) preparations for therapeutic purposes has been banned by multiple regulatory authorities (including the FDA and TGA) on the basis of their perceived toxicity. This study evaluates the toxicity of electrolytically produced (CS) preparation, as well as some compounds used to produce CS by chemical synthesis. Materials and Methods: Toxicity of the CS preparation and the chemical toxins were evaluated using the Artemia nauplii toxicity assay. Additionally, the CS was tested for its protective effects against citrate and tannic acid-induced toxicity by screening combinations of CS and the toxins. Results: The CS preparation was nontoxic in the Artemia nauplii bioassay at all concentrations tested and did not induce mortality substantially above the seawater control at all concentrations ≤50 μg/mL. In contrast, citrate and tannic acid were strongly toxic, with LC50 values of 11.6 and 26.8 μg/mL respectively. Interestingly, co-incubation of varying concentrations of the CS preparation with 30 μg/mL of citrate resulted in protection against toxicity, with 50 μg/mL CS inhibiting ~65% of citrate-induced toxicity. In contrast, the CS preparation had no apparent effects on tannic acid-induced toxicity. Conclusion: The CS preparation tested in our study was nontoxic at all concentrations tested. Furthermore, the CS mitigated the toxic effects of citrate, but had no apparent effect on tannic acid-induced toxicity. Further studies are required to verify these findings in other toxicity models and to study the protective molecular mechanisms.

    Keywords: Silver nanoparticles, Colloidal silver, Citric acid toxicity, Tannic acid, Brine shrimp toxicity, Protection against toxicity.

    DOWNLOAD PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up